|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02252 MEDBOT-B
Nominal 
16.580 -0.880 (-5.040%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | -47.464% | -60.284% | -48.276% | -25.929% | -23.432% |
| ROAE (%) | -161.068% | -104.502% | -59.820% | -30.392% | -28.432% |
| Return on Capital Employed (%) | -82.829% | -136.296% | -71.024% | -22.793% | -14.157% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 33.516% | 14.049% | 30.375% | 42.744% | N/A |
| EBITDA Margin (%) | -190.310% | -833.957% | -4727.168% | -25041.628% | N/A |
| Pre-tax Profit Margin (%) | -251.547% | -978.593% | -5306.133% | -27186.372% | N/A |
| Net Profit Margin (%) | -249.721% | -967.736% | -5276.147% | -27112.605% | N/A |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 1.701 X | 1.159 X | 3.378 X | 8.932 X | 6.619 X |
| Quick Ratio (X) | 1.400 X | 0.824 X | 2.608 X | 8.463 X | 6.619 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 79.854% | 64.861% | 27.058% | 14.389% | 15.425% |
| Total Debt / Total Assets (%) | 54.051% | 41.700% | 11.396% | 7.331% | 1.108% |
| Net Debt / Total Assets (%) | 6.184% | 6.144% | -27.356% | -62.186% | -86.745% |
| Total Debt / Shareholders' Funds (%) | 248.498% | 114.623% | 15.515% | 8.553% | 1.309% |
| Long Term Debt / Shareholders' Funds (%) | 147.948% | 33.150% | 11.408% | 6.344% | 0.803% |
| Net Debt / Shareholders' Funds (%) | 28.431% | 16.888% | -37.245% | -72.547% | -102.467% |
| Net Cash / (Debt) ($) | (79.097M) | (87.732M) | 528.012M | 1.736B | 1.478B |
| Net Cash / (Debt) per share ($) | (0.079) | (0.092) | 0.551 | 1.811 | -- |
| Total Debt / Capital Employed (%) | 89.137% | 80.180% | 13.706% | 8.003% | 1.280% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 406.539 Day | 974.403 Day | 4372.417 Day | 32580.475 Day | N/A |
| Receivables Turnover (Day) | 25.155 Day | 17.341 Day | N/A | 14.770 Day | N/A |
| Payables Turnover (Day) | 110.592 Day | 346.872 Day | 1758.388 Day | 9502.393 Day | N/A |
| Remarks: | Real time quote last updated: 03/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -642,406,000 |
| %Change | -36.532% |
| EPS / (LPS) | RMB -0.660 |
| NBV Per Share (¥) | RMB 0.276 |